Pfizer PFE

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 2- Pfizer , Lilly to resume study testing pain drug

      Headlines

      Mon, 23 Mar 2015

      March 23 (Reuters) - Pfizer Inc and Eli Lilly and Co will resume late-stage studies of their drug tanezumab for chronic pain after the U.S. Food and Drug Administration lifted a partial hold on trials of it and similar medicines.

    2. Pfizer , Lilly to resume late-stage study testing pain drug

      Headlines

      Mon, 23 Mar 2015

      March 23 (Reuters) - Pfizer Inc and Eli Lilly and Co said they planned to resume a late-stage study testing their pain drug tanezumab after the U.S. Food and Drug Administration lifted a partial...

    3. UPDATE 1-Dementia drug research aided by $100 mln venture capital fund

      Headlines

      Tue, 17 Mar 2015

      * Backers include British govt, GSK, J&J, Pfizer , Lilly, Biogen

    4. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

      Headlines

      Tue, 17 Mar 2015

      10 dividend-yielding stocks of our Ultimate Stock-Pickers since we last looked at them , with Vodafone Group VOD, Pfizer PFE , Roche RHHBY, and Eli Lilly LLY making way for Occidental Petroleum, National Oilwell Varco, Emerson Electric EMR

    5. Pfizer pain drug Lyrica fails study in adolescents with fibromyalgia

      Headlines

      Thu, 12 Mar 2015

      March 12 (Reuters) - Pfizer Inc's pain drug, Lyrica, failed a post-marketing study testing the treatment in adolescents with fibromyalgia, a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas.

    6. UPDATE 1-U.S. FDA warns of seizure, alcohol risk with Pfizer's Chantix

      Headlines

      Mon, 9 Mar 2015

      March 9 (Reuters) - The U.S. Food and Drug Administration warned on Monday that Pfizer Inc's quit-smoking drug, Chantix, has been associated with seizures and that some patients who drink while taking the drug may become aggressive or black out.

    7. U.S. FDA declines to remove serious warning on Pfizer's Chantix

      Headlines

      Mon, 9 Mar 2015

      March 9 (Reuters) - The U.S. Food and Drug Administration has declined to reduce the severity of its warning about neuropsychiatric side effects associated with Pfizer Inc's quit-smoking drug...

    8. Bull Market: More to Run

      Headlines

      Mon, 2 Mar 2015

      A activity came when pharma giant Pfizer ( PFE ) announced the acquisition of Hospira ..... over the prior-day closing price. Pfizer would pay the 40% premium on top ..... objectives is tough to do. Essentially, Pfizer management believes the market has

    9. UPDATE 1- Pfizer , Novartis say meningitis vaccine scope too narrow

      Headlines

      Thu, 26 Feb 2015

      Feb 26 (Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory committee on Thursday recommended meningitis B vaccines for people at high risk aged 10 to 25, a population that...

    10. Pfizer laments narrow recommendation for meningitis vaccine

      Headlines

      Thu, 26 Feb 2015

      Feb 26 (Reuters) - An advisory committee to the U.S. Centers for Disease Control and Prevention (CDC) has recommended that people aged 10 to 25 at increased risk of meningitis be vaccinated against the bacteria, Pfizer Inc said on Thursday.

    « Prev12345Next »
    Content Partners